Group 1 - Yifang Biotechnology's stock price fell by 5.04% on September 23, reaching 32.01 CNY per share, with a trading volume of 376 million CNY and a turnover rate of 2.69%, resulting in a total market capitalization of 18.512 billion CNY [1] - The company's stock has experienced a continuous decline for six days, with a cumulative drop of 7.59% during this period [1] - Yifang Biotechnology, established on January 11, 2013, and listed on July 25, 2022, focuses on the research, production, and sales of innovative drugs, with its main revenue source being technology licensing and cooperation, accounting for 100% of its revenue [1] Group 2 - Jin Ying Fund holds a significant position in Yifang Biotechnology, with its Jin Ying Medical Health Stock A fund (004040) owning 804,200 shares, representing 7.11% of the fund's net value, making it the second-largest holding [2] - The fund has incurred a floating loss of approximately 1.3671 million CNY today and a total floating loss of 2.2276 million CNY during the six-day decline [2] - Jin Ying Medical Health Stock A fund was established on August 1, 2017, with a current size of 140 million CNY, achieving a year-to-date return of 24.46% and a one-year return of 39.4% [2]